openPR Logo
Press release

Global Conjugate Vaccines Market Projected to Gain Significant Value by 2019-2026|GlaxoSmithKline plc., Merck Sharp & Dohme Corp, Astellas Pharma Inc., AstraZeneca

01-30-2020 10:45 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Global Conjugate Vaccines Market

Global Conjugate Vaccines Market

Global conjugate vaccines market is set to witness a healthy CAGR of 11.5% in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. Rising prevalence of infectious diseases and rising awareness about conjugate vaccines are the factor for the growth of this market.

Conjugate vaccines report provides the understanding of the most affecting driving and restraining forces in the market and its impact on the global market. More importantly, to comprehend the future outlook and prospects for the market, conjugate vaccines report is very useful. The market experts preparing this report have deeply profiled leading as well as other players of the global conjugate vaccines market with large emphasis on their market share, recent developments, business overview, markets served, and growth strategies. Moreover, this market report not only presents with the valuable insights into the competitive landscape but also concentrates on minor as well as major factors influencing the business of key market players.

Download PDF with Recent all Updates & Trending Key Players with TOC:

Few of the major competitors currently working in the global conjugate vaccines market are Novartis AG, Serum Institute of India Pvt. Ltd., Pfizer Inc, Sanofi Pasteur Limited, Bharat Biotech., Biological E, GlaxoSmithKline plc., Merck Sharp & Dohme Corp, Astellas Pharma Inc., AstraZeneca, SutroVax Inc, CSL Limited, GreenSignal Bio Pharma Private Limited, Bavarian Nordic, Taj Pharmaceuticals Limited, Affinivax, Abbott among others

Key Developments in the Market:

In November 2018, Haryana Government announced the launch of their new Pneumococcal Conjugate Vaccine which is specially designed to protect the children from pneumonia. They also launched ANMOL which is an application which will keep all their data online. The main aim of the launch is to provide cost effective and effective vaccine to the children suffering from pneumonia
In September 2018, Navi Mumbai Municipal Corporation announced the launch of their first public-sector typhoid conjugate vaccine campaign. The main aim of launching this campaign is to vaccinate around 320,000 children who are aged from 9 months to less than 15 years. The NMMC have received 100000 doses from the Bharat Biotech International Limited. This campaign will be done in two phases and there main motive is to reduce the burden of typhoid

Table Of Content:

Part 01: Executive Summary
Part 02: Scope Of The Report
Part 03: Market Landscape

Part 04: Market Sizing

Part 05: Market Segmentation By Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape
Part 08: Geographic Landscape

Part 09: Decision Framework
Part 10: Drivers And Challenges

Get Full Table Of content @

Segmentation: Global Conjugate Vaccines Market

By Type

Monovalent Conjugate Vaccines
Multivalent Conjugate Vaccines

By Disease Indication


By Pathogen Type

Bacterial Conjugate Vaccine
Viral Conjugate Vaccine
Combination (Viral and Bacterial) Conjugate Vaccine

By Patient Stage

Pediatrics Conjugate Vaccine
Adults Conjugate Vaccine

By Geography

North America
South America
Middle East and Africa

Inquiry For Customize Report With Discount at :

Data Bridge Market Research
Tel: +1-888-387-2818

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our clients needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Conjugate Vaccines Market Projected to Gain Significant Value by 2019-2026|GlaxoSmithKline plc., Merck Sharp & Dohme Corp, Astellas Pharma Inc., AstraZeneca here

News-ID: 1913996 • Views: 444

More Releases from Data Bridge Market Research

Water Treatment Chemicals Market 2020 : Witnessing Enormous Growth and Booming W …
The Global Water Treatment Chemicals Market is expected to reach USD 61.86 billion by 2026, from USD 43.6 billion in 2017 growing at a CAGR of 7.9 % during the forecast period of 2020 to 2026 Moreover increasing industrial activities and growth in world population are augmenting the market for the water treatment chemicals across the globe. Increasing water treatment chemicals prices and presence of alternate treatment technologies are predicted to
Robotic Process Automation (RPA) Market Competitive Outlook: Automation Anywhere …
A new business intelligence report released by Data Bridge Market research with titled "Global Robotic process automation Market" (covering USA, Europe, China, Japan, India, South East Asia and etc) that targets and provides comprehensive market analysis with future prospects to 2026. This rise in the market can be attributed due to rising popularity and attractiveness of enterprise resource planning which is driving the needs of the business to
Digital Assurance Market Competitive Outlook: Atos, Accenture, Capgemini, Cignit …
Data Bridge Market researchhas recently released expansive research on Global Digital Assurance Market with 100+ market data Tables, Pie Chart, Graphs & Figures spread through Pages and easy to understand detailed analysis. The report endows with wide-ranging statistical analysis of the market's continuous developments, capacity, production, production value, cost/profit, supply/demand and import/export. This market report provides best solutions for strategy development and implementation depending on client's needs to extract tangible
Rear E Axle Market Future Outlook | ZF Friedrichshafen AG, Schaeffler AG,Contine …
Front rear E axle market will register the growth rate of 23.50% for the forecast period of 2020 to 2027. Rising usage of E-axle in ICE vehicles is expected to create new opportunity for the market. Growing sales of electric and hybrid vehicles is expected to enhance the market growth. Some of the other factors such as increasing cost of the fuels, strict emissions rules to decrease the vehicle weight

All 5 Releases

More Releases for Conjugate

Global Conjugate Vaccine Market Research and Forecast, 2018-2023
Global conjugate vaccine market size, market intelligence, market trends, research and analysis report by product (multivalent, monovalent) by disease (meningococcal, diphtheria tetanus pertussis, influenza, pneumococcal) forecast 2018-2023 According to the OMR analysis, the global conjugate vaccine market is growing at a significant CAGR during 2018-2023. The global conjugate vaccine market has witnessed a significant growth due to government initiatives towards development and awareness of conjugate vaccines and longer immunity and better
Vaccine Conjugate Market Forecast by 2025: QY Research
This report studies the Vaccine Conjugate market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. The global Vaccine Conjugate market was million US$ in 2017 and is expected to million US$ by
Landscape Of The China Conjugate Vaccine Market Outlook: Ken Research
The conjugate vaccine is a type of vaccine that comprises a bacterial capsular polysaccharide, committed to a protein to improve immunogenicity and safeguard against invasive diseases. Moreover, conjugate vaccines association a weak antigen with a strong antigen so that the immune system has a stronger response to the weak antigen. Vaccines are used to avert diseases by appealing an immune response to an antigen, the foreign part of a bacteria
Conjugate Vaccine Market Share, Size & Research Report 2018-2023
Global Conjugate Vaccine Industry New Study On “2018-2023 Conjugate Vaccine Market Global Key Player, Demand, Growth, Opportunities And Analysis Forecast” Added To Wise Guy Reports Database The global conjugate vaccine market is anticipated to grow with the CAGR of 13.4% during the forecast period 2018-2023. Conjugate vaccines are similar to recombinant vaccines manufactured by the combination of two different components. Conjugate vaccines, however, are made by pieces from the coats of bacteria.
Vaccine Conjugate Market Report 2017 - 2022
About Vaccine Conjugate View Entire Report @ Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Vaccine Conjugate for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. Request for Sample of Premium Research Report with TOC @
Antibody Drug Conjugate Market Opportunity Analysis
Ever since the first attempt in the 1980's to use antibody-based drugs as therapeutic agents, the application and use of monoclonal antibody-drug conjugates has evolved in several ways. The major advantage of using Antibody Drug Conjugates (ADC) is that it brings together the best characteristics of both antibodies and the cytotoxic potential of chemotherapy. This offers significant opportunity for the future in terms of targeted accumulation of drug in the